
    
      On day 1 (day of chemotherapy), all eligible patients will receive oral NEPA (300 mg
      netupitant/0.5 mg palonosetron), 60 minutes before chemotherapy, and intravenous
      dexamethasone 12 mg, 30 minutes before chemotherapy initiation.

      For the prevention of delayed CINV, patients will be assigned randomly to one of the
      following treatment arms:

        -  Test arm A: no further anti-emetic prophylaxis on days 2 thorough 4;

        -  Test arm B: oral dexamethasone 4 mg once per day in the morning of days 2 and 3;

        -  Reference arm C: oral dexamethasone 4 mg twice per day on days 2 thorough 4.
    
  